
Apcalis SX (tadalafil)
Apcalis SX (tadalafil): explicit RSM supplier evidence, exact component/formulation context and the limits of manufacturer and clinical attribution.
ED and PE names with supplier, historical or incomplete identity evidence; see which company and formulation details are supported.
These profiles have incomplete or mixed identity evidence. Some have an explicit supplier listing; others have a historical company catalogue or only retail descriptions. That is more informative than treating every unfamiliar name as either fully verified or wholly undocumented.
Malegra DXT and Malegra FXT have historical Sunrise catalogue associations, while their current exact listings remain unconfirmed. Tadapox and Super Kamagra have RSM supplier records; those do not independently identify the producing factory. Cenforce-D belongs in the documented Centurion family and is listed separately from this group.
A familiar suffix or a similar-looking box cannot settle the ingredients, company role or local registration. Each record names what the source establishes and the specific remaining gap, without assuming that absence from one database proves export-only manufacture.

Apcalis SX (tadalafil): explicit RSM supplier evidence, exact component/formulation context and the limits of manufacturer and clinical attribution.

Kamagra Super (sildenafil + dapoxetine): explicit RSM supplier evidence, exact component/formulation context and the limits of manufacturer and clinical attribution.

Historical Sunrise Malegra DXT and DXT Plus: distinct duloxetine amounts, current identity limits and why daily PE research does not validate the combination.

Historical Sunrise Malegra FXT: sildenafil plus fluoxetine, current identity limits and the relevance of fluoxetine’s long persistence.

Nizagara is a sildenafil tablet name whose maker is reported differently by different listings. See what to check.

Sildalis combines two ED medicines, sildenafil and tadalafil, in one tablet. The maker is not established. See the concerns.

Tadapox (tadalafil + dapoxetine): explicit RSM supplier evidence, exact component/formulation context and the limits of manufacturer and clinical attribution.